267 related articles for article (PubMed ID: 11014226)
1. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
Lewis JT; Dayanandan B; Habener JF; Kieffer TJ
Endocrinology; 2000 Oct; 141(10):3710-6. PubMed ID: 11014226
[TBL] [Abstract][Full Text] [Related]
2. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
3. GIP(3-30)NH
Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
[TBL] [Abstract][Full Text] [Related]
5. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.
Baggio L; Kieffer TJ; Drucker DJ
Endocrinology; 2000 Oct; 141(10):3703-9. PubMed ID: 11014225
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
Higuchi N; Hira T; Yamada N; Hara H
Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
[TBL] [Abstract][Full Text] [Related]
9. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
Lynn FC; Pamir N; Ng EH; McIntosh CH; Kieffer TJ; Pederson RA
Diabetes; 2001 May; 50(5):1004-11. PubMed ID: 11334402
[TBL] [Abstract][Full Text] [Related]
10. GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.
Lu SC; Chen M; Atangan L; Killion EA; Komorowski R; Cheng Y; Netirojjanakul C; Falsey JR; Stolina M; Dwyer D; Hale C; Stanislaus S; Hager T; Thomas VA; Harrold JM; Lloyd DJ; Véniant MM
Cell Rep Med; 2021 May; 2(5):100263. PubMed ID: 34095876
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR
Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578
[TBL] [Abstract][Full Text] [Related]
12. Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists.
Naylor J; Suckow AT; Seth A; Baker DJ; Sermadiras I; Ravn P; Howes R; Li J; Snaith MR; Coghlan MP; Hornigold DC
Biochem J; 2016 Sep; 473(18):2881-91. PubMed ID: 27422784
[TBL] [Abstract][Full Text] [Related]
13. Human GIP(3-30)NH
Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
[TBL] [Abstract][Full Text] [Related]
14. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
Lynn FC; Thompson SA; Pospisilik JA; Ehses JA; Hinke SA; Pamir N; McIntosh CH; Pederson RA
FASEB J; 2003 Jan; 17(1):91-3. PubMed ID: 12475913
[TBL] [Abstract][Full Text] [Related]
15. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
16. GIP(3-30)NH
Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
[TBL] [Abstract][Full Text] [Related]
17. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.
Puddu A; Sanguineti R; Montecucco F; Viviani GL
J Diabetes Res; 2015; 2015():326359. PubMed ID: 26221611
[TBL] [Abstract][Full Text] [Related]
18. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
19. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
20. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
